Xinteza API
Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.
About
Xinteza API enhances the natural production of ultra-pure cannabinoid active ingredients through disruptive discoveries of novel genes, genetic pathways, and molecules. They make a wide array of natural, lab-made cannabinoids, including minor and modified ones, more accessible for producing innovative Active Pharma Ingredients and high-end Consumer Packaged Goods. Xinteza USA leverages this technology to produce pharma-grade cannabinoids at competitive prices for the pharmaceutical and CPG industries. Teams look it up for Biotech, Cannabis, Genetics.
Frequently asked
What does Xinteza API do?
Xinteza API is a Biotech company that offers Services. Teams look it up for Cannabis, Genetics, Drug Discovery. It is based in San Francisco, United States and was founded in 2021. Public records show about 4 people and $10M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Xinteza API raised?
Xinteza API has raised a total of $10M in funding. The most recent round on record is Seed.
Where is Xinteza API headquartered?
Xinteza API is headquartered in San Francisco, United States.
When was Xinteza API founded?
Xinteza API was founded in 2021.
What industry does Xinteza API operate in?
Xinteza API operates in Biotech, Cannabis, Genetics, Drug Discovery, Genomics.
How many employees does Xinteza API have?
Xinteza API has approximately 4 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.